Management — NMD Pharma
Biopeople Newsletter January 2020 - Biopeople
Thomas Holm Pedersen – CEO – NMD Pharma | LinkedIn
NMD Pharma - Inkef capital
Management — NMD Pharma
NMD Pharma brænder 41 mio. kr. af sin kæmpeinvestering
NMD Pharma - Inkef capital
Prominent Canadian researcher in Denmark: Why I left a top job in California
NMD Pharma A/S | LinkedIn
NMD Pharma Receives Approval to Start a combined Phase I/IIa Clinical Trial of NMD670 for the Treatment of Symptoms of Myasthenia Gravis
Management — NMD Pharma
Rare Neuromuscular Disease Company NMD Pharma Raises USD 3 Million in Seed Financing Round - Lundbeckfonden
Dutch MG Clinical Trial Will Test NMD670 Oral Therapy Candidate
NMD Pharma
News — NMD Pharma
Biotech completes financing round to advance neuromuscular treatments - EPM Magazine
NMD Pharma - Inkef capital
NMD Pharma Initiates a Combined Phase I/IIa Clinical Trial of NMD670 for the Treatment of Symptoms of Myasthenia Gravis
NMD Pharma - PIR International
NMD Pharma
